An announcement from Scilex Holding Company ( (SCLX) ) is now available.
On March 10, 2025, Scilex Holding Company announced a change in the record date for its previously announced dividend of Series 1 Mandatory Exchangeable Preferred Stock. The new record date is set for April 11, 2025, replacing the initially announced date of January 28, 2025. This adjustment impacts stockholders and certain securityholders, with the payment date to be determined within 60 days following the new record date. The announcement highlights the company’s strategic financial maneuvers and its potential implications for stakeholders, emphasizing the Board’s discretion in altering the record date and payment conditions.
More about Scilex Holding Company
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for treating acute and chronic pain. The company targets indications with high unmet needs and large market opportunities, offering products like ZTlido®, ELYXYB®, and Gloperba®. Scilex is also involved in developing treatments for neurodegenerative and cardiometabolic diseases through a proposed joint venture with IPMC Company.
YTD Price Performance: -20.64%
Average Trading Volume: 1,470,458
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $84.33M
For detailed information about SCLX stock, go to TipRanks’ Stock Analysis page.